BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Laube R, Sabih AH, Strasser SI, Lim L, Cigolini M, Liu K. Palliative care in hepatocellular carcinoma.J Gastroenterol Hepatol. 2021;36:618-628. [PMID: 32627853 DOI: 10.1111/jgh.15169] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Dennis C, Prince DS, Moayed-alaei L, Remash D, Carr-boyd E, Bowen DG, Strasser SI, Crawford M, Pulitano C, Kench J, Mccaughan GW, Mckenzie C, Liu K. Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.997093] [Reference Citation Analysis]
2 Shkaraburov AS, Rudenko DN, Vaiman EF, Soboleva OM, Zakharova YV. Asymptomatic Hepatocellular Carcinoma (Clinical Case). Kreativnaâ hirurgiâ i onkologiâ 2022;12:256-260. [DOI: 10.24060/2076-3093-2022-12-3-256-260] [Reference Citation Analysis]
3 Verma M, Kalman R, Horrow J, Gallagher M, Woodrell C, Navarro V. Feasibility of a Palliative Care Intervention within Routine Care of Hepatocellular Carcinoma: A Pilot Randomized Controlled Trial. J Palliat Med 2022. [PMID: 36149682 DOI: 10.1089/jpm.2022.0338] [Reference Citation Analysis]
4 Jacobs G, Boyle DA, El‐serag HB, Lewandowski RJ, Stein SM, Lazure P, Mcfadden P. Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionals. Cancer Medicine. [DOI: 10.1002/cam4.5216] [Reference Citation Analysis]
5 Norman EML, Weil J, Philip J. Hepatocellular carcinoma and its impact on quality of life: A review of the qualitative literature. Eur J Cancer Care (Engl) 2022;:e13672. [PMID: 35974658 DOI: 10.1111/ecc.13672] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Jonas E, Bernon M, Robertson B, Kassianides C, Keli E, Asare KO, Alatise IO, Okello M, Blondel NO, Mulehane KO, Abubeker ZA, Nogoud AA, Nashidengo PR, Chihaka O, Tzeuton C, Dusheiko G, Sonderup M, Spearman CW. Treatment of hepatocellular carcinoma in sub-Saharan Africa: challenges and solutions. The Lancet Gastroenterology & Hepatology 2022. [DOI: 10.1016/s2468-1253(22)00042-5] [Reference Citation Analysis]
7 Mansouri V, Rezaei N. Interdisciplinary Approach in Hepatobiliary Cancers. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_70] [Reference Citation Analysis]
8 Remash D, Prince DS, McKenzie C, Strasser SI, Kao S, Liu K. Immune checkpoint inhibitor-related hepatotoxicity: A review. World J Gastroenterol 2021; 27(32): 5376-5391 [PMID: 34539139 DOI: 10.3748/wjg.v27.i32.5376] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
9 Buranupakorn T, Thangsuk P, Patumanond J, Phinyo P. Emulation of a Target Trial to Evaluate the Causal Effect of Palliative Care Consultation on the Survival Time of Patients with Hepatocellular Carcinoma. Cancers (Basel) 2021;13:992. [PMID: 33673534 DOI: 10.3390/cancers13050992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhu Z, Yu R, Yang C, Li D, Wang J, Yang W, Ji Y, Wang L, Wang Y, Jiang F. Stress-related hormone reduces autophagy through the regulation of phosphatidylethanolamine in breast cancer cells. Ann Transl Med 2021;9:149. [PMID: 33569451 DOI: 10.21037/atm-20-8176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Prince D, Liu K, Xu W, Chen M, Sun JY, Lu XJ, Ji J. Management of patients with intermediate stage hepatocellular carcinoma. Ther Adv Med Oncol 2020;12:1758835920970840. [PMID: 33224278 DOI: 10.1177/1758835920970840] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]